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ABSTRACT 
In this study, the antibacterial and cytotoxic activities of isolated compounds from the roots of Onosma visianii 
were investigated. By using different chromatographic techniques and appropriate spectroscopic methods, the 
seven naphthoquinones were described: deoxyshikonin (1), isobutyrylshikonin (2), -methylbutyrylshikonin (3), 
acetylshikonin (4), -hydroxyisovalerylshikonin (5), 5,8-O-dimethyl isobutyrylshikonin (6) and 5,8-O-dimethyl 
deoxyshikonin (7). Among the tested compounds, 3 and 4 exhibited the highest antibacterial activities toward all 
tested bacterial species (MIC50 and MIC90 for gram positive bacteria: 6.40g/mL-12.79g/mL and 6.82g/mL-
13.60g/mL, respectively; for gram negative bacteria: 4.27g/mL-8.53g/mL and 4.77g/mL-9.54g/mL, re-
spectively). Also, naphthoquinones 3 and 4 exhibited strong cytotoxic activity against MDA-MB-231 cells (IC50 
values 86.0 g/mL and 80.2 g/mL, respectively), while compounds 1, 3, 4 and 5 significantly decreased viability 
of HCT116 cells (IC50 values of 97.8g/mL, 15.2 g/mL, 24.6g/mL and 30.9g/mL, respectively). Our results 
indicated that all tested naphthoquinone pigments are potential candidates for clinical uses as antibacterial and 
cytotoxic agents.  
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INTRODUCTION 
The emergence of antibiotic resistance 
presents one of the most important challenges 
for the pharmaceutical industry and the 
healthcare sector both in the developing and 
developed countries. The inadequate and ex-
cessive use of antibiotics, significantly dimin-
ishes the efficacy of current drugs, at the same 
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time demanding new drugs against multi-drug 
resistant bacteria (Gyles, 2011). Another ma-
jor health problem is cancer. It affects about 
two hundred types of cell lines, causing lack 
of control of the cell proliferation and differ-
entiation while invading various tissues and 
organs. There are many difficulties in the 
treatment of these diseases, especially in 
terms of drug resistance, toxicity, and low 
specificity. Although the official medicine 
has shown effective results, herbal medicinal 
products successfully act on some kinds of 
these ailments. 
The genus Onosma L. (Boraginaceae) 
contains about 150 species, distributed mainly 
in the Mediterranean region and Central Asia 
(El-Shazly et al., 2003). 
The roots of Onosma sericeum Willd., 
Onosma microcarpum DC., Onosma ar-
gentata Hub.-Mor. and Onosma armeniaca 
Klokov have been widely used in traditional 
medicine for the treatment of wounds, burns, 
dyspnea, hoarseness, hemorrhoids, ab-
dominal aches and stomach ulcers (Sezik et 
al., 1997; Davis, 1988; Cadirci et al., 2007). 
Phytochemical investigation of the roots 
of genus Onosma has led to the discovery of 
a series of shikonin and alkannin derivatives, 
as compounds which exhibit a wide spectrum 
of biological properties, like wound healing, 
antiinflammatory, antitumor, antimicrobial 
and antithrombotic properties (Papageorgiou  
et al., 1999, 2008; Wang et al., 2015; Naz et 
al., 2006). On the other hand, literature re-
ported that aerial parts contain pyrrolizidine 
alkaloids (El-Shazly et al., 2003; Damianakos 
et al., 2013) and phenolic compounds 
(Mellidis et al., 1993). 
Onosma visianii Clem (Boraginaceae) is 
a biennial to perennial plant which inhabits 
areas of Balkan Peninsula and Southeast Eu-
rope. The point of view of the chemical com-
position, O. visianii is little investigated. Ex-
cept that it contains shikonin 
(Shcherbanovskii, 1971), other literature data 
relating to chemical composition and pharma-
cological activity do not exist. 
We herein report for the first time isola-
tion and structural characterization of these 
naphthoquinones from the roots of O. visianii. 
Also, antibacterial activity against ten bacte-
rial species, as well as cytotoxic activity 
against MDA-MB-231 and HCT116 tumor 
cell lines was described. 
 
MATERIALS AND METHODS 
Chemicals 
Petroleum ether (boiling point ranges: 
40 °C-60 °C), methylene chloride, ethyl ace-
tate, deuterochloroform (CDCl3), dimethyl 
sulfoxide (DMSO) and HPLC grade methanol 
were obtained from Sigma-Aldrich (Stein-
heim, Germany). Water was treated in a Milli-
Q water purification system (TGI Pure Water 
Systems, Brea, CA, USA). Mueller Hinton 
agar was obtained from Merck (Germany). 
Nutrient liquid medium, Mueller Hinton broth 
was purchased from Biolife (Italy). 3-(4,5-Di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was obtained from SERVA 
(Heidelberg, Germany). Annexin V-FITC/7-
AAD Kit was purchased from Beckman Coul-
ter (USA). Standard antibiotics, Cisplatin, 
Phosphate-buffered saline (PBS), Ribonucle-
ase A (RNAse A), fetal bovine serum (FBS) 
and 7-Aminoactinomycin D (7-AAD) were 
obtained from Sigma-Aldrich (Steinheim, 
Germany).  
 
Instrumentation 
Microanalysis of carbon and hydrogen 
was carried out with a Carlo Erba 1106 micro-
analyser. Infrared spectra were run on 
Thermo Scientific Nicolet 6700 FT-IR spec-
trometer (4000-400 cm-1) and Perkin-Elmer 
FT-IR Spectrometer Spectrum One (KBr 
disc,  in cm-1). The NMR spectra were rec-
orded on a Varian Gemini 200 spectrometer 
(1H at 200 MHz and 13C at 50 MHz) and a 
BrukerAvance III 500 spectrometer (1H at 
500.26 MHz and 13C at 125.80 MHz), solvent 
CDCl3, TMS internal standard. Chemical 
shifts were given in  (ppm), J-coupling con-
stants in Hertz (Hz), abbreviations: s-singlet, 
d-doublet, dd-doublet of doublet, t-triplet, m-
multiplet, br s-broadend singlet. Low resolu-
tion mass spectra were recorded on an Agilent 
5973 mass spectrometer (Santa Clara, CA, 
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USA). High resolution mass spectra were ob-
tained on a Agilent 6210 Time of Flight 
(TOF) mass spectrometer (Agilent Technolo-
gies, Santa Clara, CA, USA) and linear-trap 
quadrupole (LTQ) orbitrap hybrid mass spec-
trometer equipped with a heated-electrospray 
ionization probe (HESI-II, ThermoFisher Sci-
entific, Bremen, Germany). []D values were 
measured in dichloromethane using a Perkin 
Elmer 341 polarimeter. UV/VIS spectra were 
recorded on an Agilent Cary 300 UV-VIS 
spectrophotometer (Agilent Technologies, 
Palo Alto, USA). MALDI TOF MS (Matrix 
Assisted Laser Desorption Ionization-Time of 
Flight Mass Spectrometry) Biotyper (Bruker 
Daltonics, Billerica, USA) was used for con-
firmation of test bacteria. Semi preparative 
high performance liquid chromatography was 
performed on Agilent 1100 Series liquid chro-
matograph (Agilent Technologies, Santa 
Clara, CA, USA) equipped with diode array 
detector (DAD; 520 nm, 450 nm), au-
tosampler, and fraction collector; conditions: 
injection volume, 600 L (2 mg/mL, metha-
nol); column Zorbax Eclipse XDB C18 
(250mm x 9.4 mm; 5 m); mobile phase 
(6 mL/min), water (40 %) and methanol 
(60 %). Silica gel 60 (Merck, 70-230 mesh) 
was used for column chromatography. Pre-
parative TLC was performed by using silica 
gel P/UV254 with CaSO4 (Machery-Nagel, 
Germany, 2 mm layer of adsorbent). Analyti-
cal TLC was performed on silica gel (Silica 
gel 60, layer 0.20 mm, Alugram Sil G, Mash-
ery-Nagel, Germany).  
 
Plant material 
O. visianii Clem roots were collected 
(June 2015) in the region of mountain Rumija 
(southern Montenegro, altitude 650 m, 42º 
06’ 10’’ N, 19º 11’ 37’’ E). A voucher herbar-
ium specimen was deposited at the Depart-
ment of Botany, Faculty of Biology, Univer-
sity of Belgrade, Serbia (17130, BEOU). 
 
Extraction method 
Dried roots (135 g) of O. visianii were 
powdered and extracted at room temperature 
three times with a (1500 mL, 24 h) petroleum 
ether-methylene chloride mixture (1:1). The 
combined extracts were evaporated under re-
duced pressure to give concentrated extract as 
red-brown semi-viscous residue (6.5 g).  
 
General procedure for isolation of  
compounds  
The petroleum ether-methylene chloride 
extract (6 g) was subjected to silica gel col-
umn chromatography. The column was eluted 
with petroleum ether (100 %), followed by an 
increasing gradient of ethyl acetate starting 
from 1 % up to 30 %. Twenty-nine collected 
fractions were analyzed on TLC plates using 
petroleum ether:methylene chloride (97:3 and 
95:5) and petroleum ether:ethyl acetate (95:5) 
solvent systems. Similar fractions were com-
bined (F1-11, F12-15, F16-20, F21-23 and 
F24-29) and further subjected to preparative 
TLC. Used mobile phases: for F1-11 and 
F12-15 petroleum ether:ethyl acetate (8:2), 
for F16-20 and F21-23 petroleum ether:ethyl 
acetate (7:3), for F24-29 petroleum 
ether:ethyl acetate (6:4). After TLC examina-
tions, compounds 1 and 2 were obtained from 
F1-11, 2 and 3 were obtained from F12-15, 
from F16-20 3, 4 and 5, from F21-23 was iso-
lated compound 5, while F24-29 provided 
compounds 6 and 7. In order to obtain high 
purity, all isolated compounds were subjected 
to semi preparative HPLC on Zorbax Eclipse 
XDB C18 reversed phase column with iso-
cratic elution of mixture water and methanol 
(40:60).  
 
Spectroscopic data of isolated compounds 
1-7 
Deoxyshikonin 1  
(5,8-dihydroxy-2-(4-methylpent-3-
enyl)naphthalene-1,4-dione). Red purple 
solid. UV/VIS (MeOH, nm) max () 552 
(3.33), 515 (3.41), 486 (3.34), 277 (3.80), 216 
(4.47); IR (KBr, cm-1) 3650-3160 (OH), 3055 
(=CH), 2923 (CH), 1621, 1573 and 1457 
(C=C), 1222 and 1102 (C-O); 1H NMR (500 
MHz, CDCl3, TMS, ppm) 1.60 (3H, s, H-
16), 1.70 (3H, s, H-15), 2.28 (2H, m, H-11), 
2.60 (2H, m, H-12a, H-12b), 5.13 (1H, t, 
J=7.1 Hz, H-13), 6.84 (1H, s, H-3), 7.21 (2H, 
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s, H-6 and H-7), 12.48 (1H, s, OH-5) and 
12.64 (1H, s, OH-8); 13C NMR (125 MHz, 
CDCl3, TMS, ppm) 17.9 (C-16), 25.7 (C-
15), 26.4 (C-12), 29.7 (C-11), 111.6 (C-9), 
111.8 (C-10), 122.3 (C-13), 130.7 (C-6), 
131.0 (C-7), 133.5 (C-14), 134.5 (C-3), 151.5 
(C-2), 161.9 (C-5 or C-8), 162.6 (C-8 or C-5), 
183.2 (C-1 or C-4) and 183.3 (C-4 or C-1); 
HRESIMS m/z [M-H]-=271.0956 (error -
3.340 ppm; calc to C16H15O4 m/z 271.0970). 
Isobutyrylshikonin 2  
[(+)-1-(5,8-dihydroxy-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl)-4-methylpent-3-enyl 
isobutyrate]. Red purple solid. []D25 (di-
chloromethane, C=0.00121) +321. UV/VIS 
(MeOH, nm) max () 556 (3.21), 518 (3.48), 
489 (3.49), 275 (3.81), 217 (4.73); IR (KBr, 
cm-1) 3680-3630 (OH), 3074 and 3048 
(=CH), 2965, 2925 and 2853 (CH), 1735 
(C=O from COOCH(CH3)2), 1607, 1569 and 
1457 (C=C), 1238, 1213, 1146 and 1116 (C-
O); 1H NMR (500 MHz, CDCl3, TMS, ppm) 
1.20 (3H, d, J=7.0 Hz, H-3’), 1.22 (3H, d, 
J=7.0 Hz, H-4’), 1.58 (3H, s, H-16), 1.69 (3H, 
s, H-15), 2.47 (1H, m, H-12a), 2.62 (1H, m, 
H-12b), 2.64 (1H, m, H-2’), 5.12 (1H, t, J=7.5 
Hz, H-13), 6.02 (1H, dd, J=7.2 Hz, J=4.5 Hz, 
H-11), 6.97 (1H, s, H-3), 7.18 (2H, s, H-6 and 
H-7), 12.42 (1H, s, OH-5) and 12.58 (1H, s, 
OH-8); 13C NMR (125 MHz, CDCl3, TMS, 
ppm) 17.9 (C-16), 18.9 (C-3’ and C-4’), 25.7 
(C-15), 32.8 (C-12), 33.9 (C-2’), 68.8 (C-11), 
111.4 (C-9), 111.8 (C-10), 117.7 (C-13), 
131.3 (C-3), 132.5 (C-6), 132.8 (C-7), 135.9 
(C-14), 148.5 (C-2), 166.6 (C-5 or C-8), 167.3 
(C-8 or C-5), 175.7 (C-1’), 176.7 (C-1 or C-
4) and 178.3 (C-4 or C-1); HRESIMS m/z [M-
H]-=357.1320 (error -3.654 ppm; calc to 
C20H21O6 m/z 357.1338). 
-Methylbutyrylshikonin 3  
[(+)-1-(5,8-dihydroxy-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl)-4-methylpent-3-enyl 
2-methylbutanoate]. Red purple solid. []D25 
(dichloromethane, C=0.00121) +221. 
UV/VIS (MeOH, nm) max () 557 (3.20), 518 
(3.47), 489 (3.38), 275 (3.87), 216 (4.53); IR 
(KBr, cm-1) 3660-3622 (OH), 3041 (=CH), 
2970, 2932 and 2878 (CH), 1742 (C=O from 
COOCH(CH3)CH2CH3), 1610, 1571 and 
1455 (C=C), 1232, 1204, 1148 and 1113 (C-
O); 1H NMR (500 MHz, CDCl3, TMS, ppm) 
0.93 (3H, t, J=7.3 Hz, H-4’), 1.17 (3H, d, 
J=7.0 Hz, H-5’), 1.53 (2H, m, H-3’), 1.59 
(3H, s, H-16), 1.69 (3H, s, H-15), 2.27 (1H, 
m, H-2’), 2.47 (1H, m, H-12a), 2.61 (1H, m, 
H-12b), 5.13 (1H, t, J=7.0 Hz, H-13), 6.04 
(1H, dd, J=7.4 Hz, J=4.3 Hz, H-11), 6.98 (1H, 
s, H-3), 7.18 (2H, s, H-6 and H-7), 12.42 (1H, 
s, OH-5) and 12.58 (1H, s, OH-8); 13C NMR 
(125 MHz, CDCl3, TMS, ppm) 11.4 (C-4’), 
17.9 (C-16), 18.8 (C-5’), 25.7 (C-15), 26.7 
(C-3’), 33.0 (C-12), 41.0 (C-2’), 69.0 (C-11), 
111.6 (C-9), 111.8 (C-10), 117.8 (C-13), 
131.3 (C-2), 132.6 (C-6), 132. 8 (C-7), 135.9 
(C-14), 148.6 (C-3), 166.9 (C-5 or C-8), 167.4 
(C-8 or C-5), 175.3 (C-1’), 176.7 (C-1 or C-
4), and 178.3 (C-4 or C-1); HRESIMS m/z 
[M-H]-=371.1473 (error -4.405 ppm; calc to 
C21H23O6 m/z 371.1495). 
Acetylshikonin 4  
[(+)-1-(5,8-dihydroxy-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl)-4-methylpent-3-enyl 
acetate]. Red purple solid. []D25 (dichloro-
methane, C=0.00135) +692. UV/VIS 
(MeOH, nm) max () 556 (3.21), 518 (3.48), 
490 (3.41), 273 (3.89), 215 (4.53); IR (KBr, 
cm-1) 3650-3620 (OH), 3065 (=CH), 2921 
and 2859 (CH), 1732 (C=O from COOCH3), 
1604, 1575 and 1454 (C=C), 1236, 1209, 
1114 and 1049 (C-O); 1H NMR (500 MHz, 
CDCl3, TMS, ppm) 1.58 (3H, s, H-16), 1.69 
(3H, s, H-15), 2.14 (3H, s, H-2’), 2.46 (1H, m, 
H-12a), 2.61 (1H, m, H-12b), 5.12 (1H, t, 
J=6.1 Hz, H-13), 6.02 (1H, dd, J=7.4 Hz, 
J=4.2 Hz, H-11), 7.00 (1H, s, H-3), 7.18 (2H, 
s, H-6 and H-7), 12.43 (1H, s, OH-5) and 
12.58 (1H, s, OH-8); 13C NMR (125 MHz, 
CDCl3, TMS, ppm) 17.9 (C-16), 20.9 (C-
2'), 25.7 (C-15), 32.8 (C-12), 69.5 (C-11), 
111.5 (C-9), 111.8 (C-10), 117.7 (C-13), 
131.4 (C-2), 132.7 (C-6), 132.9 (C-7), 136.1 
(C-14), 148.1 (C-3), 166.9 (C-5 or C-8), 167.4 
(C-8 or C-5), 169.6 (C-1’), 176.8 (C-1 or C-
4) and 178.2 (C-4 or C-1); HRESIMS m/z [M-
H]-=329.1004 (error -4.663 ppm; calc to 
C18H17O6 m/z 329.1025). 
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-Hydroxyisovalerylshikonin 5  
[(+)-1-(5,8-dihydroxy-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl)-4-methylpent-3-enyl 
3-hydroxy-3-methylbutanoate]. Red purple 
solid. []D25 (dichloromethane, C=0.00111) 
+91. UV/VIS (MeOH, nm) max () 556 
(3.19), 518 (3.48), 489 (3.40), 276 (3.97), 217 
(4.54). IR (KBr, cm-1) 3680-3620 (OH), 3043 
(=CH), 2974, 2927 and 2853 (CH), 1737 
(C=O from COOCH2C(CH3)2OH), 1612, 
1571 and 1455 (C=C), 1264, 1204, 1111 and 
1154 (C-O); 1H NMR (500 MHz, CDCl3, 
TMS, ppm) 1.31 (6H, s, H-4’, H-5’), 1.59 
(3H, s, H-16), 1.69 (3H, s, H-15), 2.50 (1H, 
m, H-12a), 2.59 (3H, s, H-2’), 2.63 (1H, m, 
H-12b), 3.26 (1H, br s, C-3’-OH), 5.12 (1H, t, 
J=6.7 Hz, H-13), 6.10 (1H, dd, J=7.8 Hz, 
J=4.2 Hz, H-11), 7.03 (1H, s, H-3), 7.18 (2H, 
s, H-6 and H-7), 12.41 (1H, s, OH-5) and 
12.60 (1H, s, OH-8); 13C NMR (125 MHz, 
CDCl3, TMS, ppm) 18.3 (C-16), 25.7 (C-
15), 29.2 (C-4’), 29.5 (C-5’), 33.1 (C-12), 
46.5 (C-2’), 69.1 (C-3’), 69.8 (C-11), 111.5 
(C-9), 111.8 (C-10), 117.7 (C-13), 131.3 (C-
2), 133.1 (C-6), 133.3 (C-7), 136.4 (C-14), 
147.5 (C-3), 168.2 (C-5 or C-8), 168.7 (C-8 or 
C-5), 171.6 (C-1’), 175.3 (C-1 or C-4) and 
176.9 (C-4 or C-1); HRESIMS m/z [M-H]-
=387.1419 (error -4.958 ppm; calc to 
C21H23O7 m/z 387.1444). 
5,8-O-Dimethyl isobutyrylshikonin 6  
[(+)-1-(5,8-dimethoxy-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl)-4-methylpent-3-enyl 
isobutyrate]. Orange oil. []D25 (dichloro-
methane, C=0.00111) +289. UV/VIS 
(MeOH, nm) max () 452 (3.45), 259 (4.11), 
215 (4.79); IR (KBr, cm-1) 3044 (=CH), 2919 
and 2847 (CH), 1732 (C=O from 
COOCH(CH3)2), 1650 and 1457 (C=C), 
1278, 1155 and 1058 (C-O); 1H NMR (500 
MHz, CDCl3, TMS, ppm) 1.18 (3H, d, 
J=4.0 Hz, H-3’), 1.19 (3H, d, J=4.0 Hz, H-4’), 
1.57 (3H, s, H-16), 1.66 (3H, s, H-15), 2.44 
(1H, m, H-12a), 2.60 (1H, m, H-12b), 3.96 
(6H, s, C-5-OCH3, C-8-OCH3), 5.12 (1H, t, 
J=7.5 Hz, H-13), 5.90 (1H, dd, J=7.5 Hz, 
J=4.5 Hz, H-11), 6.65 (1H, s, H-3), 7.31 (2H, 
s, H-6 and H-7); 13C NMR (125 MHz, CDCl3, 
TMS, ppm) 17.9 (C-16), 18.9 (C-3’ and C-
4’), 20.9 (C-2’), 25.7, (C-15), 32.8 (C-12), 
56.8 (C-5-OCH3 or C-8-OCH3), 56.9 (C-8-
OCH3 or C-5-OCH3), 69.7 (C-11), 118.1 (C-
13), 120.1 (C-7), 120.6 (C-9, C-10), 131.3 (C-
3), 133.3 (C-6), 135.6 (C-14), 148.3 (C-2), 
153.0 (C-5 or C-8), 154.0 (C-8 or C-5), 169.5 
(C-1’), 183.3 (C-1 or C-4), 184.5 (C-4 or C-
1); HRESIMS m/z [M+H]+=387.1824 (error 
4.226 ppm; calc to C22H27O6 m/z 387.1808). 
5,8-O-Dimethyl deoxyshikonin 7  
(5,8-dimethoxy-2-(4-methylpent-3-
enyl)naphthalene-1,4-dione). Dark orange 
oil. UV/VIS (MeOH, nm) max () 443 (3.33), 
259 (4.21), 216 (4.75); IR (KBr, cm-1) 3054 
(=CH), 2923 and 2823 (CH), 1644 and 1448 
(C=C), 1278, 1207, 1046 and 1018 (C-O); 1H 
NMR (500 MHz, CDCl3, TMS, ppm) 1.58 
(3H, s, H-16), 1.67 (3H, s, H-15), 2.24 (1H, 
m, H-12a), 2.52 (3H, m, H-11, H-12b), 3.95 
(6H, s, C-5-OCH3, C-8-OCH3), 5.12 (1H, t, 
J=6.4, Hz, H-13), 6.60 (1H, s, H-3), 7.30 (2H, 
s, H-6 and H-7); 13C NMR (125 MHz, CDCl3, 
TMS, ppm) 17.9 (C-16), 25.8, (C-15), 32.8 
(C-12), 56.8 (C-5-OCH3 or C-8-OCH3), 56.9 
(C-8-OCH3 or C-5-OCH3), 69.7 (C-11), 118.1 
(C-13), 120.1 (C-7), 120.6 (C-9, C-10), 133.3 
(C-6), 134.5 (C-3), 135.6 (C-14), 151.4 (C-2), 
153.0 (C-5 or C-8), 154.0 (C-8 or C-5), 183.3 
(C-1 or C-4), 184.5 (C-4 or C-1); HRESIMS 
m/z [M+H]+= 301.1450 (error 3.373 ppm; 
calc to C18H21O4 m/z 301.1439). 
 
Antibacterial activity  
Bacteria 
Antibacterial activity was tested against 
five gram positive bacteria (Bacillus mega-
terium, Enterococcus faecalis, Microbacte-
rium arborescens, Micrococcus luteus and 
Staphylococcus epidermidis) and five gram 
negative bacteria (Citrobacter koseri, Hafnia 
alvei, Pseudomonas proteolytica, Stenotroph-
omonas maltophilia and Yersinia intermedia). 
The tested bacteria (as clinical isolates; con-
firmed via MALDI TOF MS Biotyper, Bruker 
Daltonics, Billerica, USA) were provided 
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from a collection of Department of Microbi-
ology, Faculty of Biotechnology and Food 
Sciences, Nitra, Slovakia. 
Suspension preparation  
All microorganisms were kept on -80 °C. 
Cultures of bacteria were incubated on 
Mueller Hinton agar (Merck, Germany) for 
24 h at 36 °C. Regulation of initial suspension 
turbidity was conducted by comparison with 
0.5 McFarland’s standard (Andrews, 2005). 
Initial bacterial suspensions contained about 
108 CFU/mL. In addition, 1:100 dilutions of 
initial suspension were made into sterile 0.85 
% NaCl.  
Micro-dilution antibacterial assay  
Minimal inhibitory concentrations 
(MICs) were determined by the microbroth 
dilution method according to the Clinical and 
Laboratory Standards Institute document 
(CLSI, 2009) in Mueller Hinton broth (Bi-
olife, Italy). Briefly, the DMSO solutions of 
isolated naphthoquinones (or standard antibi-
otics) were prepared as serial two-fold dilu-
tions with the final concentrations ranging be-
tween 0.25-512 g/mL. After that, each well 
was inoculated with microbial suspension at 
the final density of 0.5 McFarland. After 24 h 
of incubation at 37 °C, the inhibition of mi-
crobial growth was evaluated by measuring 
the well absorbance at 450 nm in an absorb-
ance microplate reader Biotek EL808 with 
shaker (Biotek Instruments, USA). The 96-
microtiter plates were read before and after 
experiment. Measurement error was estab-
lished for 0.05 values of absorbance. Wells 
without tested naphthoquinones (or standard 
antibiotics) were used as negative controls of 
growth. Pure DMSO was used as a negative 
control. This experiment was done in eight-
replicates for a higher accuracy of the MICs 
of tested compounds.  
Statistical analysis for antibacterial activity 
Differences in absorbance between the 
measurements before and after the analysis 
were expressed as a set of binary values. 
These values were assigned to exact concen-
trations. The following formula was created 
for this specific experiment: value 1 (inhibi-
tory effect) was assigned to absorbance values 
lower than 0.05, while value 0 (no effect or 
stimulant effect) was assigned to absorbance 
values higher than 0.05. For this statistical 
evaluation the probit analysis in Statgraphics 
software was used.  
 
Cytotoxicity 
Drugs and chemicals 
Tested isolated naphthoquinones were di-
luted in DMSO at the concentration of 
200 g/mL, filtered through a 0.22 m Milli-
pore filter before use, and diluted by a cell 
culture medium to diverse working concen-
trations, so that the final concentration of 
DMSO in cell culture medium never ex-
ceeded 0.5 % (v/v). 
Cell lines 
Human breast carcinoma cell line MDA-
MB-231 and colon cancer cell line HCT116 
were purchased from the American Type Cul-
ture Collection (ATCC, USA) and cultured as 
suggested by the supplier. Both cell lines were 
sustained in culture medium supplemented 
with 10 % heat-inactivated FBS.  
MTT cell viability assay 
MDA-MB-231 and HCT116 cells were 
plated onto microtiter plates at density of 5 x 
104/mL and allowed to adhere overnight. 
Cells were then treated with tested substances 
at indicated concentrations, or with media 
alone (control). The plates were incubated for 
24, 48 and 72 h at 37 °C in an atmosphere of 
5 % CO2 and absolute humidity. The media 
was removed and 100 L of MTT 
(0.5 mg/mL PBS) was added to each well. Af-
ter 4h incubation at 37 °C, MTT solution was 
removed and 150 L of DMSO was added to 
dissolve the formazan crystals. Absorbance 
was measured with a multiplate reader (Zen-
ith 3100, Anthos Labtec Instruments GmbH, 
Austria) at 595 nm (Mosmann, 1983). The 
IC50 values were calculated using Microsoft 
Office Excel free add-in (ed50v10.xls.) for 
linear regression downloaded from 
http://www.sciencegateway.org/proto-
cols/cellbio/drug/data/. 
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Cell cycle analysis 
MDA-MB-231 and HCT116 cells were 
incubated with media alone (control) or with 
100 g/mL of compounds 1-5 and 500 g/mL 
of compounds 6 and 7. After 48 h at 37 °C in 
an atmosphere of 5 % CO2 and absolute hu-
midity, both attached and detached cells were 
collected, washed in PBS and fixed with 70 % 
ethanol at 4 °C. Fixed cells were washed in 
PBS and finally resuspended in 1mL PBS 
containing RNAse A (500 g/mL). After 
30 min incubation at 37 °C, cells were stained 
with 5 L PI (10 mg/mL PBS), incubated for 
15 min in the dark and immediately analyzed 
by flow cytometer Cytomics FC500 (Beck-
man Coulter, USA). Distribution of cells with 
different DNA content was determined with 
Flowing Software (http://www.flowingsoft-
ware.com/) and presented by histograms.  
Determination of apoptosis/necrosis by  
flow cytometry 
Apoptosis was determined using Annexin 
V-FITC/7-AAD Kit. MDA-MB-231 and 
HCT116 cells were incubated with media 
alone (control) or with 100 g/mL of com-
pounds 1-5 and 500 g/mL of compounds 6 
and 7. After 48 h incubation at 37 °C in the 
atmosphere containing 5 % CO2, both at-
tached and detached cells were collected. Af-
ter washing with PBS, cells were resuspended 
in 500 L of ice cold binding buffer. Ten L 
of Annexin V-FITC and 20 L of 7-AAD 
were added and after 15 min incubation in the 
dark, 400 L of binding buffer was added to 
each tube. Samples were analyzed by flow cy-
tometer Cytomics FC500 (Beckman Coulter, 
USA). Data were analyzed using Flowing 
Software and presented by dot plots.  
 
RESULTS AND DISCUSSION 
Isolation and structural analysis of naph-
thoquinone derivatives from the roots of O. 
visianii 
Separation of petroleum ether-methylene 
chloride root extract of O. visianii using open 
column chromatography, preparative thin 
layer chromatography, as well as semiprepar-
ative HPLC, resulted in isolation of seven 
pure naphthoquinone derivatives: deoxy-
shikonin (1) (19 mg), isobutyrylshikonin (2) 
(38 mg), -methylbutyrylshikonin (3) 
(63 mg), acetylshikonin (4) (166 mg), -hy-
droxyisovalerylshikonin (5) (131 mg), 5,8-O-
dimethyl isobutyrylshikonin (6) (18 mg) and 
5,8-O-dimethyl deoxyshikonin (7) (32 mg) 
(Figure 1). Structural identification of all iso-
lated naphthoquinones was performed by 
spectroscopic techniques listed in experi-
mental part, as well as by comparison of ob-
tained data with those previously published in 
the literature (Kretschmer et al., 2012; Ozgen 
et al., 2004; Albreht et al., 2009; Wang et al., 
2015; Zhou et al., 2010). Among isolated 
compounds, 5,8-O-dimethyl isobutyrylshi-
konin (6) was found in nature for the first 
time. 
The compounds 1-5 showed IR absorp-
tions in the region of 3680-3160 cm-1 which 
indicated presence of OH groups attached to 
naphthoquinone moiety, as well as tertiary 
OH group from hydroxyisovaleryl part of 
compound 5. Except in the cases of 1 and 7, 
observed stretching vibrations of compounds 
2-6 in the region of 1742-1732 cm-1 belong to 
the aliphatic ester C=O groups. Also, for all 
isolated naphthoquinones (1-7), strong bands 
from C-O groups were noted (at 1278-1018 
cm-1). The 1H NMR spectra of 1-5 showed 
two deshielded protons from hydroxyl groups 
attached to C-5 and C-8 carbons from naph-
thoquinone part (12.41 ppm-12.64 ppm). 
Also, compound 5 contains one additional 
broadened singlet (at 3.26 ppm) from hy-
droxyl group linked to C-3’. Instead of sin-
glets of OH protons, resonances from C-5-
OCH3 and C-8-OCH3 groups (singlets at 3.95 
ppm and 3.96 ppm, respectively) were ob-
served in the 1H NMR spectra of 6 and 7 (as 
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dimethoxy derivatives). In contrast to other 
isolated compounds (for 2-6, doublet of dou-
blets in the region of 6.02 ppm-6.10 ppm), de-
oxyshikonin 1 and it 5,8-dimethoxy deriva-
tive 7 showed signals of C-11-H protons at 
lower fields (multiplets at 2.28 ppm and 2.52 
ppm, respectively). All derivatives contain 
characteristic triplets from vinyl C-13-H pro-
tons (at 5.12 ppm-5.13 ppm), singlets from C-
3-H protons (naphthoquinone moiety; at 6.60 
ppm-7.03 ppm), as well as singlets from C-H-
6 and C-H-7 protons (naphthoquinone moi-
ety; at 7.18 ppm-7.31 ppm). In the 13C NMR 
spectra of 2-6, signals from C-1’ carbons (at 
169.5 ppm-175.7 ppm) were recorded, indi-
cating the presence of aliphatic ester C=O 
groups. These signals were not observed in 
cases of compounds 1 and 7, as deoxy-
shikonin and its dimethoxy derivative. Also, 
in contrast to isolated compounds 2 and 1, 
5,8-dimethoxy derivatives 6 and 7 showed 
two additional signals from C-5-OCH3 and C-
8-OCH3 carbons (56.8 ppm and 56.9 ppm, re-
spectively). Finally, the positive values of 
measured optical rotations ([]D25) confirmed 
that isolated naphthoquinones 2-6 from the 
roots of O. visianii are shikonin derivatives. 
 
 
Figure 1: Chemical structures of isolated naph-
thoquinones 1-7 
 
 
In vitro activity of the isolated  
naphthoquinones against bacteria  
The seven isolated naphthoquinones were 
evaluated for their antibacterial activity 
against the five gram positive and five gram 
negative bacteria (Table 1). Resistance of 
used bacteria was presented in Table 1, while 
the activities of isolated compounds (as 
MIC50 and MIC90 in g/mL, respectively) 
were showed in Table 2. Observed MIC50 and 
MIC90 values of isolated naphthoquinones are 
in the range of 4.27 g/mL-68.27 g/mL and 
4.77g/mL-76.20g/mL, respectively. In 
accordance with literature (Noundou et al., 
2016), compounds which exhibited MIC val-
ues equal or less than 16 g/mL were consid-
ered to have possible clinical relevance. Fol-
lowing these facts, erythromycin, ampicillin 
and vancomycin resistant B. megaterium is 
the most sensitive bacteria against tested com-
pounds 1, 3 and 4, ampicillin and vancomycin 
resistant E. faecalis against compounds 3, 4 
and 5, while other three gram positive bacteria 
are sensitive against 3 and 4. Among gram 
negative bacteria, meropenem resistant S. 
maltophilia is susceptible to 2, 3, and 4, while 
other four bacteria showed high sensitivity 
against compounds 3 and 4. Previously pub-
lished data indicated notable activity of shi-
konin derivatives against gram positive bacte-
ria (and generally low activity against gram 
negative bacteria), with the fact of remarkable 
differences of antibacterial potency due to dif-
ferent approaches of measuring MIC values 
(Papageorgiou et al., 1999; Andujar et al., 
2013). On the other hand, some results 
showed good antibacterial activity against 
some gram negative species (Brigham et al., 
1999; Ding et al., 2011). Our results indicated 
that isolated naphthoquinone derivatives at 
the same time showed a good activity towards 
both gram positive and gram negative bacte-
ria.  
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Table 1: Antibacterial activity of tested antibiotics  
Bacteria 
Compound 
1GEN 2ERY 3AMP 4TETc 5IMPe 6MEM 7PIP 8TGC 9VAN 10NOR 11CHL
12MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 
13MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 
μg/mL 
gram positive 
B. megaterium 
4.55 
± 0.15 
48.95 
± 1.21 
94.23 
± 1.35 
1.21 
± 0.01 
4.65 
± 0.21 
7.69 
± 0.11 
7.71 
± 0.09 
7.62 
± 0.11 
98.55 
± 1.12 
4.59 
± 0.03 
5.23 
± 0.14 
4.98 
± 0.17 
89.25 
± 1.31 
135.65 
± 1.22 
1.29 
± 0.03 
5.05 
± 0.22 
8.16 
± 0.12 
7.89 
± 0.11 
8.45 
± 0.12 
140.10 
± 1.19 
4.77 
± 0.04 
6.24 
± 0.16 
E. faecalis 
4.56 
± 0.08 
6.11 
± 0.05 
99.55 
± 0.78 
5.12 
± 0.09 
8.55 
± 0.11 
4.99 
± 0.14 
5.54 
± 0.12 
0.59 
± 0.03 
110.10 
± 1.36 
0.41 
± 0.01 
6.12 
± 0.11 
4.69 
± 0.09 
8.25 
± 0.06 
136.69 
± 0.89 
7.69 
± 0.14 
15.11 
± 0.16 
7.16 
± 0.16 
9.12 
± 0.15 
0.85 
± 0.05 
160.54 
± 1.59 
0.52 
± 0.03 
6.99 
± 0.12 
M. arborescens 
0.99 
± 0.01 
95.22 
± 0.99 
107.98 
± 0.97 
5.12 
± 0.05 
5.11 
± 0.13 
13.55 
± 0.11 
6.60 
± 0.11 
14.55 
± 0.26 
78.12 
± 1.24 
8.80 
± 0.25 
16.44 
± 0.36 
1.22 
± 0.03 
119.88 
± 1.31 
149.88 
± 1.16 
6.63 
± 0.07 
7.19 
± 0.19 
16.22 
± 0.17 
11.80 
± 0.12 
21.68 
± 0.29 
116.20 
± 1.46 
14.25 
± 0.35 
21.50 
± 0.38 
M. luteus 
5.21 
± 0.07 
151.29 
± 1.64 
6.12 
± 0.06 
5.88 
± 0.13 
5.88 
± 0.15 
8.11 
± 0.09 
11.23 
± 0.09 
11.33 
± 0.13 
16.40 
± 0.23 
5.50 
± 0.18 
79.40 
± 1.89 
6.31 
± 0.13 
159.63 
± 1.66 
7.55 
± 0.07 
7.15 
± 0.17 
8.52 
± 0.17 
14.55 
± 0.13 
18.10 
± 0.18 
20.40 
± 0.18 
25.55 
± 0.28 
9.87 
± 0.23 
99.55 
± 1.96 
S. epidermidis 
111.11 
± 0.97 
117.77 
± 1.11 
84.12 
± 0.16 
90.50 
± 1.35 
13.56 
± 0.11 
5.22 
± 0.11 
12.20 
± 0.06 
5.10 
± 0.06 
4.62 
± 0.18 
11.69 
± 0.34 
15.50 
± 0.26 
153.11 
± 0.13 
138.11 
± 1.16 
99.09 
± 0.18 
135.44
± 1.39 
18.99 
± 0.12 
5.89 
± 0.17 
18.99 
± 0.08 
7.56 
± 0.09 
5.05 
± 0.26 
18.60 
± 0.39 
17.58 
± 0.28 
gram negative 
C. koseri 
4.98 
± 0.13 
5.13 
± 0.19 
91.12 
± 1.34 
7.85 
± 0.17 
0.56 
± 0.01 
2.12 
± 0.06 
9.78 
± 0.13 
0.33 
± 0.02 
15.10 
± 0.18 
12.20 
± 0.15 
5.50 
± 0.16 
6.56 
± 0.14 
5.23 
± 0.20 
113.15 
± 1.41 
10.14 
± 0.18 
0.78 
± 0.03 
3.15 
± 0.08 
16.65 
± 0.21 
0.51 
± 0.03 
17.25 
± 0.19 
18.21 
± 0.17 
5.90 
± 0.18 
H. alvei 
8.11 
± 0.07 
8.55 
± 0.09 
89.33 
± 0.89 
6.11 
± 0.07 
0.79 
± 0.01 
0.51 
± 0.01 
12.66 
± 0.45 
0.65 
± 0.01 
17.25 
± 0.12 
14.20 
± 0.13 
5.05 
± 0.06 
8.89 
± 0.08 
11.49 
± 1.00 
134.54 
± 0.22 
7.56 
± 0.07 
0.86 
± 0.02 
0.55 
± 0.02 
17.55 
± 0.51 
0.78 
± 0.02 
24.44 
± 0.13 
22.41 
± 0.18 
5.43 
± 0.08 
P. proteolytica 
86.88 
± 1.33 
12.55 
± 0.19 
6.30 
± 0.03 
4.57 
± 0.09 
1.11 
± 0.06 
1.68 
± 0.16 
91.12 
± 1.65 
7.56 
± 0.06 
6.88 
± 0.11 
8.99 
± 0.15 
12.11 
± 0.13 
99.61 
± 1.36 
16.54 
± 0.21 
6.73 
± 0.04 
6.11 
± 0.13 
1.53 
± 0.08 
1.99 
± 0.17 
131.16
± 1.71 
7.99 
± 0.07 
12.40 
± 0.15 
17.45 
± 0.16 
14.40 
± 0.14 
S. maltophilia 
4.56 
± 0.06 
6.88 
± 0.04 
5.88 
± 0.03 
1.12 
± 0.08 
0.96 
± 0.03 
111.11
± 1.33 
16.25 
± 0.22 
5.97 
± 0.15 
11.10 
± 0.08 
0.56 
± 0.02 
9.80 
± 0.21 
5.05 
± 0.08 
7.55 
± 0.05 
7.12 
± 0.05 
1.29 
± 0.09 
1.54 
± 0.09 
139.55
± 1.36 
19.36 
± 0.23 
8.12 
± 0.19 
17.10 
± 0.09 
0.77 
± 0.03 
10.56 
± 0.29 
Y. intermedia 
5.77 
± 0.12 
11.11 
± 0.14 
111.25 
± 1.39 
5.41 
± 0.07 
1.45 
± 0.07 
1.13 
± 0.07 
11.25 
± 0.16 
0.71 
± 0.02 
16.10 
± 0.19 
5.40 
± 0.07 
16.30 
± 0.21 
7.03 
± 0.13 
16.87 
± 0.18 
137.12 
± 1.40 
5.82 
± 0.08 
2.11 
± 0.09 
1.78 
± 0.08 
12.88 
± 0.18 
0.79 
± 0.03 
18.55 
± 0.23 
9.80 
± 0.09 
19.54 
± 0.27 
1GEN-Gentamycin, 2ERY-Erythromycin, 3AMP-Ampicillin, 4TETc-Tetracycline, 5IMPe-Imipenem, 6MEM-Meropenem, 7PIP- Pipe-
racillin, 8TGC-Tigecycline, 9VAN-Vancomycin, 10NOR-Norfloxacin, 11CHL-Chloramphenicol, 12MIC50 and 13MIC90 values are means 
of eight measurements (Mean value ± SD). 
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Table 2: Antibacterial activity of tested naphthoquinones 
Bacteria 
Compound 
1 2 3 4 5 6 7 
1MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 
2MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 MIC90 
μg/mL 
gram positive 
B. megaterium 
12.79 ± 0.56 34.13 ± 0.65 12.79 ± 0.33 8.53 ± 0.29 34.13 ± 0.55 34.13 ± 0.42 51.07 ± 0.36
13.60 ± 0.61 38.10 ± 0.69 13.60 ± 0.35 9.54 ± 0.30 38.10 ± 0.58 38.10 ± 0.46 54.28 ± 0.39
E. faecalis 
34.13 ± 0.44 25.58 ± 0.33 6.40 ± 0.99 8.53 ± 0.45 12.79 ± 0.19 34.13 ± 0.45 25.58 ± 0.29
38.10 ± 0.46 27.20 ± 0.36 6.82 ± 1.12 9.54 ± 0.48 13.60 ± 0.23 38.10 ± 0.46 27.20 ± 0.30
M. 
arborescens 
34.13 ± 0.23 25.58 ± 0.28 12.79 ± 1.26 6.40 ± 0.12 17.07 ± 0.22 51.07 ± 0.35 34.13 ± 0.33
38.10 ± 0.29 27.20 ± 0.29 13.60 ± 1.28 6.82 ± 0.16 19.05 ± 0.26 54.28 ± 0.39 38.10 ± 0.38
M. luteus 
68.27 ± 0.19 25.58 ± 0.11 12.79 ± 1.13 8.53 ± 0.19 34.13 ± 0.18 51.07 ± 0.21 51.07 ± 0.28
76.20 ± 0.22 27.20 ± 0.13 13.60 ± 1.16 9.54 ± 0.22 38.10 ± 0.19 54.28 ± 0.26 54.28 ± 0.29
S. epidermidis 
34.13 ± 0.29 34.13 ± 0.25 8.53 ± 0.35 8.53 ± 0.15 34.13 ± 0.23 51.07 ± 0.33 51.07 ± 0.29
38.10 ± 0.35 38.10 ± 0.28 9.54 ± 0.39 9.54 ± 0.17 38.10 ± 0.29 54.28 ± 0.33 54.28 ± 0.31
gram negative 
C. koseri 
34.13 ± 0.65 17.07 ± 0.15 6.40 ± 0.17 8.53 ± 0.17 68.27 ± 0.66 34.13 ± 0.29 17.07 ± 0.16
38.10 ± 0.66 19.05 ± 0.19 6.82 ± 0.19 9.54 ± 0.18 76.20 ± 0.87 38.10 ± 0.33 19.05 ± 0.18
H. alvei 
51.07 ± 0.39 51.07 ± 0.36 8.53 ± 0.17 6.40 ± 0.09 34.13 ± 0.32 34.13 ± 0.21 17.07 ± 0.14
54.28 ± 0.48 54.28 ± 0.37 9.54 ± 0.18 6.82 ± 0.10 38.10 ± 0.33 38.10 ± 0.23 19.05 ± 0.15
P. proteolytica 
34.13 ± 0.33 17.07 ± 0.21 6.40 ± 0.29 4.27 ± 0.06 17.07 ± 0.13 68.27 ± 0.64 34.13 ± 0.29
38.10 ± 0.35 19.05 ± 0.23 6.82 ± 0.26 4.77 ± 0.08 19.05 ± 0.13 76.20 ± 0.75 38.10 ± 0.35
S. maltophilia 
34.13 ± 0.29 12.79 ± 0.09 4.27 ± 0.22 6.40 ± 0.14 34.13 ± 0.18 68.27 ± 0.77 68.27 ± 0.63
38.10 ± 0.31 13.60 ± 0.12 4.77 ± 0.23 6.82 ± 0.19 38.10 ± 0.19 76.20 ± 0.79 76.20 ± 0.66
Y. intermedia 
25.58 ± 0.21 25.58 ± 0.16 6.40 ± 0.16 6.40 ± 0.12 68.27 ± 0.26 68.27 ± 0.56 12.79 ± 0.15
27.20 ± 0.22 27.20 ± 0.17 6.82 ± 0.18 6.82 ± 0.13 76.20 ± 0.29 76.20 ± 0.59 13.60 ± 0.17
1MIC50 and 2MIC90 values are means of eight measurements (Mean value ± SD). 
 
 
Among the isolated compounds, α-
methylbutyrylshikonin 3 and acetylshikonin 4 
exhibited the highest antibacterial activities 
toward all tested bacterial species. Observed 
MIC50 and MIC90 values for gram positive 
bacteria are in the range of 6.40 µg/mL-
12.79 μg/mL and 6.82 μ g/mL-13.60 μg/mL, 
respectively, while for gram negative bacteria 
are in the range of 4.27 μg/mL-8.53 μg/mL 
and 4.77 μg/mL-9.54 μg/mL, respectively. 
The shikonin derivative 3 had strong potency 
against E. faecalis (MIC50 6.40 μg/mL and 
MIC90 6.82 μg/mL), as well as against S. 
maltophilia (MIC50 4.27 μg/mL and MIC90 
4.77 µg/mL), while compound 4 was very ac-
tive against M. arborescens (MIC50 
6.40 μg/mL and MIC90 6.82 μg/mL) and P. 
proteolytica (MIC50 4.27 μg/mL and MIC90 
4.7 μg/mL). In contrast to previous report that 
alkylation of the phenolic groups leads to 
lower activity (Papageorgiou et al., 1999), we 
herein reported that gram negative ampicillin 
resistant bacteria Y. intermedia was very sus-
ceptible against compound 7 as dimethoxy 
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derivative of deoxyshikonin (MIC50 
12.79 μg/mL and MIC90 13.60 μg/mL). 
From the above mentioned results, in 
cases of developed resistance (or in cases of 
preventing resistance) examined naphthoqui-
nones may substitute clinical antibiotics. 
 
Cytotoxic activity of isolated  
naphthoquinones 
Cytotoxic activity of compounds 1-7 
against two cancer cell lines was performed 
by conducting MTT cell viability assays. 
Generally, tested compounds decreased via-
bility of both tumor cell lines in a dose and 
time dependent manner. Yet, the extent of cy-
totoxicity on the designated cell lines was di-
verse, being more potent on HCT116 cell line 
(Figure 2, Table 3). 
As observed in Table 3, -methylbutyr-
ylshikonin 3 and acetylshikonin 4 exhibited 
the highest cytotoxic activity against MDA-
MB-231 cells compared to all other tested 
substances with (IC50 values 86.0 g/mL and 
80.2 g/mL, respectively). Also, all examined 
compounds, except compounds 6 and 7, de-
creased viability of MDA-MB-231 cells after 
48 hours of incubation. However, HCT116 
cells were generally more sensitive to the ef-
fects of isolated naphthoquinones. Compound 
3 showed the strongest cytotoxic effect 
against HCT116 cells with IC50 value of 15.2 
g/mL. Also, compounds 1, 4 and 5 signifi-
cantly decreased viability of HCT116 cells 
and these compounds exhibited IC50 values of 
97.8g/mL, 24.6g/mL and 30.9g/mL, re-
spectively. The results presented in Table 3 
are in accordance with the previously pub-
lished data of cytotoxicity of shikonin deriva-
tives against many cancer cell lines. Among 
1500 tested quinones, about 150 compounds 
showed strong in vivo activity against W256 
in rats and P388 lymphoid leukemia in mice, 
as well as significant in vitro potency toward 
KB cells and CCRF-CEM leukemia cells (Pa-
pageorgiou et al., 1999). On the other hand, 
isolated quinones demonstrated significant in 
vitro potency toward KB cells, CCRF-CEM 
leukemia cells, as well as some melanoma cell 
lines (Papageorgiou et al., 1999; Kretschmer 
et al., 2012). To determine whether cytotoxi-
city induced by naphthoquinones was due to 
apoptosis or cell cycle arrest, the cells were 
stained with fluorescent dyes and analyzed on 
flow cytometer. 
 
Naphthoquinones induce apoptosis in 
 tumor cell lines 
Flow cytometric analysis showed that pri-
mary type of cell death in MDA-MB231 cells, 
induced by isolated naphthoquinones, was 
apoptosis, with small proportion of necrotic 
cells, whereas percent of necrotic cells was 
considerable higher only in cells treated with 
compound 4 (Figure 3).  
 
Table 3: IC50 (g/mL) values determined by MTT assay for investigated compounds, after 24 h, 48 h 
and 72 h treatment of MDA-MB-231 and HCT116 cells 
 
aIC50 values (μg/mL) 
MDA MB-231 HCT116 
24 h 48 h 72 h 24 h 48 h 72 h 
1 > 500 155.5 ± 14.5 118.9 ± 17.8 164.6 ± 13.9 124.4 ± 14.6 97.8 ± 8.7 
2 > 500 435.4 ± 29.5 424.7 ± 34.6 > 500 395.2 ± 37.4 202.1 ± 18.4
3 > 500 149.5 ± 17.7 86.0 ± 11.5 311.5 ± 22.1 22.5 ± 6.3 15.2 ± 4.5 
4 > 500 242.5 ± 26.8 80.2 ± 9.9 188.7 ± 19.2 49.2 ± 7.2 24.6 ± 6.6 
5 > 500 173.9 ± 14.6 204.6 ± 17.2 288.8 ± 23.9 36.2 ± 7.8 30.9 ± 6.9 
6 > 500 > 500 411.5 ± 24.3 > 500 > 500 127.6 ± 9.4 
7 > 500 > 500 391.6 ± 42.0 > 500 > 500 485.2 ± 28.2
cisplatin 127.59 ± 15.6 2n.d. 34.23 ± 6.7 79.10 ± 7.9 n.d. 31.32 ± 5.9 
1IC50 values (given as Mean value ± SD) are obtained from three independent experiments in triplicate, 2n.d.-not determined 
EXCLI Journal 2017;16:73-88 – ISSN 1611-2156 
Received: November 09, 2016, accepted: January 03, 2017, published: February 16, 2017 
 
 
84 
 
Figure 2: Cell viability of MDA-MB-231 and HCT116 cell lines after 24 h, 48 h and 72 h treatment with 
diverse concentrations of tested naphthoquinones, estimated by MTT assay (results from three separate 
experiments; mean value ± SD) 
 
 
 
Similarly, in HCT116 cells, the supreme 
type of cell death induced by naphthoqui-
nones was apoptosis and again, only com-
pound 4 induced similar percent of both apop-
tosis and necrosis (Figure 3). The scope of 
cancer therapy is to promote apoptosis, a type 
of cell death that is, unlike necrosis, limited to 
cells committed to die and does not affect sur-
rounding tissue. Therefore, agents that induce 
apoptosis in cancer cells can be useful in can-
cer treatment.  
 
Naphthoquinones induce cell cycle arrest in 
tumor cell lines 
A 48 hour treatment of MDA-MB-231 
cells with compounds 3-7 resulted in signifi-
cant increase in percentage of the cells assem-
bled in G2/M phase, with concomitant de-
crease in percentage of cells in G0/G1 phase 
(p < 0.05) (Figure 4).  
The percentage of MDA-MB-231 cells 
batched in G2/M phase increased from 7.6 % 
in control to 14.0 % - 40.8 % in treated cells. 
Additionally, compared to control, com-
pounds 5, 6 and 7 showed a significant rise in 
the number of the cells arrested at S phase (3.2 
%, 10.1 %, 25.4 % and 27.1 % respectively). 
Compounds 1 and 2 showed no changes in 
cell cycle profile of MDA-MB-231 cells (Fig-
ure 4). Similarly, treatment of HCT116 cells 
with compounds 3, 4, 5 and 6 resulted in in-
crease of G2/M phase cells from 30.7 % (con-
trol) to 38.9 %-49.6 %, with most pronounced 
arrest when treated with compound 3 
(p < 0.05). Contrary, treatment with com-
pounds 2 and 7 showed an increasing trend in 
the number of the cells arrested at G0/G1 
phase: quantitatively it was 24.3 % and 
14.7 % respectively over the control values. 
Compound 1 showed no changes in cell cycle 
profile of HCT116 cells (Figure 4 and Figure 
5). 
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Figure 3: Flow cytometric analysis of Annexin V-FITC/7-AAD stained MDA-MB-231 (A) and HCT116 
(B) cells (The percentages of early apoptotic (Annexin V+7-AAD-, lower right quadrant), late apoptotic 
(Annexin V+7-AAD+, upper right quadrant) and necrotic cells (Annexin V-7-AAD+, upper left quadrant) 
in untreated and treated cells are indicated on dot plots) 
 
Physiologically, cell cycle and apoptosis 
are directly connected. In damaged cells, 
stopping the cell cycle, gives cells a time to 
activate repair mechanisms and fix the dam-
age. If the damage can’t be fixed, apoptosis 
program is activated. Contrary, uncontrolled 
progression of the cell cycle and avoidance of 
apoptosis are the main characteristics of ma-
lignant cells (Hanahan and Weinberg, 2000). 
Our results demonstrated that naphthoqui-
nones arrest mitosis and make the cell cycle 
stopped in G0/G1, S or G2/M phases resulting 
in cellular apoptosis of target cells. The dif-
ference between cytotoxic effects of isolated 
naphthoquinones on selected tumor cell lines, 
was probably caused by different molecular 
targets of these compounds (Narang and De-
sai, 2009). Literature reported that activity of 
naphthoquinones was closely related to do 
presence of quinone part, with the facts that 
mode of cytotoxic action includes oxidative 
stress, as well as inhibition of topoisomerase 
I and topoisomerase II (Papageorgiou et al, 
1999). Thus, G0/G1 arrest in HCT116 (com-
pounds 2 and 7) or S phase arrest in MDA-
MB-231 (compounds 6 and 7) point to block-
ade of DNA replication and inhibition of 
topoisomerase II and I as a possible mecha-
nism that triggers apoptosis (Huang et al., 
2003), whereas G2/M arrest coupled with de-
creased expression of cyclin-dependent ki-
nases 1 and 2 with contribution from ROS-
mediated pathways (Pan et al., 2015) may be 
responsible for apoptosis of MDA-MB-231 
cells induced by compounds 3-7. 
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Figure 4: Flow cytometric analysis of cell cycle (histograms present cell cycle distribution in untreated 
and treated MDA-MB-231 (A) and HCT116 (B) cells) 
 
 
 
Figure 5: Effect of naphthoquinones on cell cycle (bars present cell cycle distribution in untreated and 
treated MDA-MB-231 (A) and HCT116 (B) cells) 
 
 
CONCLUSIONS 
In this study, for the first time we presents 
that roots of O. visianii are a rich source of 
bioactive naphthoquinone derivatives which 
possess strong activity toward selected re-
sistant bacterial strains, as well as high cyto-
toxic activity against MDA-MB-231 and 
HCT116 tumor cell lines. According to our 
results,-methylbutyrylshikonin 3 and ace-
tylshikonin 4 showed notable activities to-
ward all tested gram positive and gram nega-
tive bacterial species. Also, compounds 3 and 
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4 exhibited strong cytotoxic potency against 
MDA-MB-231 cells, while compounds 3, 4 
and 5 showed the strongest cytotoxic effect 
toward HCT116 cells. Overall, this research 
provided a strong indication of the potential 
use of O. visianii naphthoquinone pigments as 
antibacterial and cytotoxic agents.  
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